UK 464273

Drug Profile

UK 464273

Alternative Names: UK 464,273

Latest Information Update: 10 Aug 2009

Price : $50

At a glance

  • Originator Pfizer
  • Class Erectile dysfunction therapies
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Premature ejaculation

Most Recent Events

  • 10 Aug 2009 Discontinued - Phase-II for Premature ejaculation in USA (unspecified route)
  • 07 Jan 2005 Phase-II clinical trials in Premature ejaculation in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top